Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: In vitro studies in normolipidemic and dyslipidemic humanplasmas

Citation
Km. Wasan et al., Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: In vitro studies in normolipidemic and dyslipidemic humanplasmas, J PHARM SCI, 88(2), 1999, pp. 185-190
Citations number
22
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACEUTICAL SCIENCES
ISSN journal
00223549 → ACNP
Volume
88
Issue
2
Year of publication
1999
Pages
185 - 190
Database
ISI
SICI code
0022-3549(199902)88:2<185:DITLDO>2.0.ZU;2-E
Abstract
The purpose of these studies was to determine the distribution of a lipophi lic antimalarial agent, halofantrine hydrochloride (Hf), in fasted plasma f rom hypo-, normo-, and hyperlipidemic patients that displayed differences i n lipoprotein concentration and lipid transfer protein I (LTP I) activity. To assess the influence of modified lipoprotein concentrations and LTP I ac tivity on the plasma distribution of Hf, Hf at a concentration of 1000 ng/m L was incubated in either hypo-, normo-, or hyperlipidemic human plasma for 1 h at 37 degrees C. Following incubation, the plasma samples were separat ed into their lipoprotein and lipoprotein-deficient plasma (LPDP) fractions by density gradient ultracentrifugation and assayed for Hf by high-pressur e liquid chromatography. The activity of LTP I in the dyslipidemic plasma s amples was determined in terms of its ability to transfer cholesteryl ester from low-density lipoproteins (LDL) to high-density lipoproteins (HDL). To tal plasma and lipoprotein cholesterol (esterified and unesterified), trigl yceride, and protein levels in the dyslipidemic plasma samples were determi ned by enzymatic assays. When Hf was incubated in normolipidemic plasma for 1 h at 37 degrees C, the majority of drug was found in the LPDP fraction. When Hf was incubated in human plasma of varying total lipid, lipoprotein l ipid, and protein concentrations and LTP I activity, the following relation ships were observed. As the triglyceride-rich lipoprotein (TRL) lipid and p rotein concentration increased from hypolipidemia through to hyperlipidemia , the proportion of Hf associated with TRL increased (r > 0.90). As the HDL lipid and protein concentration increased, the proportion of Hf associated with HDL decreased (r > 0.70). As the total and lipoprotein lipid levels i ncreased, the LTP I activity of the plasma also proportionally increased (r > 0.85). Furthermore, with the increase in LTP I activity, the proportion of Hf associated with the TRL fraction increased (r > 0.70) and the proport ion of Hf associated with the HDL fraction decreased (r > 0.80). In additio n, a positive correlation between the proportion of apolar lipid and Hf rec overed within each lipoprotein fraction was observed within hypo- (r > 0.80 ), normo- (r = 0.70), and hyperlipidemic (r > 0.90) plasmas. These findings suggest that changes in the HDL and TRL lipid and protein concentrations, LTP I activity, and the proportion of apolar lipid within each lipoprotein fraction may influence the plasma lipoprotein distribution of Hf in dyslipi demia.